The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
300 jobs Number of planned job creations
Announcement Date
7 June 2022
Employment effect (start)
7 June 2022
Foreseen end date
31 December 2023
Description
Swedish-British pharmaceutical manufacturer Astra Zeneca has announced to recruit 300 employees in Gothenburg. A majority of the open positions will be for researchers. According to the company, approximately half of the new employees will work in laboratories and focus on developing new medicine.
In parallel to the recruitment process, Astra Zeneca invests 100 million SEK (approximately €10 million) in research.
According to its website, the company has over 76,00 employees worldwide. Approximately 4,600 of them are located in Sweden. In Gothenburg, Astra Zeneca employs 2,600 people.
Eurofound (2022), Astra Zeneca, Business expansion in Sweden, factsheet number 106945, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/106945.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
